SUPRECUR

This brand name is authorized in Austria, Estonia, Japan, Malta, United Kingdom

Active ingredients

The drug SUPRECUR contains one active pharmaceutical ingredient (API):

1 Buserelin UNII 13U86G7YSP - BUSERELIN ACETATE

Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonadotrophin release, it down-regulates the hypothalanic-pituitary-gonadal axis. Read about Buserelin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUPRECUR Nasal spray solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
SUPRECUR Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02AE01	Buserelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1040443
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39296, 42566
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499701R1052
Country: MT	Medicines Authority	Identifier(s): AA770/06102